Johnson & Johnson

JNJ · NYSE · USD

$256.03−1.02%−$2.63

Close · October 2, 2026

At a glance

Revenue growth: +6.05%; 2025 vs 2024
Net income growth: +90.56%; 2025 vs 2024
Net margin: 28.5%; 2024: 15.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total assets	199,210	180,104	167,558	187,378	182,018	174,894	157,728	152,954	157,303	141,208
Current assets	55,624	55,893	53,495	55,294	60,979	51,237	45,274	46,033	43,088	65,032
Cash and equivalents	19,709	24,105	21,859	12,889	14,487	13,985	17,305	18,107	17,824	18,972
Short-term investments	393	417	1,068	9,392	17,121	11,200	1,982	1,580	472	22,935
Receivables	17,178	14,842	14,873	14,039	15,283	13,576	14,481	14,098	13,490	11,699
Inventory	14,191	12,444	11,181	10,268	10,387	9,344	9,020	8,599	8,765	8,144
Net property, plant and equipment	24,469	21,618	20,898	18,982	19,862	19,766	18,658	17,035	17,005	15,912
Goodwill	48,772	44,200	36,558	36,047	35,246	36,393	33,639	30,453	31,906	22,805
Other intangible assets	50,403	37,618	34,175	38,489	46,392	53,402	47,643	47,611	53,228	26,876
Long-term investments	1,575	5,524	9,069	1,189	2,384	2,219	1,887	517	758	900
Current liabilities	54,126	50,321	46,282	55,802	45,226	42,493	35,964	31,230	30,537	26,287
Accounts payable	11,991	10,311	9,632	9,889	11,055	9,505	8,544	7,537	7,310	6,918
Long-term debt	39,438	30,651	25,881	26,886	29,985	32,635	26,494	27,687	30,684	22,824
Total debt	42,838	33,600	28,450	29,537	33,116	35,534	28,594	30,323	32,183	24,528
Total liabilities	117,666	108,614	98,784	110,574	107,995	111,616	98,257	93,202	97,143	70,790
Total equity (incl. minority)	81,544	71,490	68,774	76,804	74,023	63,278	59,471	59,752	60,160	70,418
Retained earnings	168,978	155,791	153,843	128,345	123,060	113,890	110,659	106,216	101,793	110,551